Notably, the evidence suggesting that blood levels of HMGB2 may serve as diagnostic markers for early-stage liver fibrosis and cirrhosis underscores its potential role in the early development of HCC (50), providing a window for preventive interventions aimed at mitigating disease progression. Here, HMGB2 is linked to hepatocellular carcinoma.